S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Biden's latest bailout--terrible for America? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
Biden's latest bailout--terrible for America? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Biden's latest bailout--terrible for America? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Biden's latest bailout--terrible for America? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
Biden's latest bailout--terrible for America? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Biden's latest bailout--terrible for America? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Biden's latest bailout--terrible for America? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
Biden's latest bailout--terrible for America? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Biden's latest bailout--terrible for America? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Biden's latest bailout--terrible for America? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
Biden's latest bailout--terrible for America? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Biden's latest bailout--terrible for America? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
NASDAQ:SNY

Sanofi (SNY) Stock Forecast, Price & News

$51.49
+0.66 (+1.30%)
(As of 06/6/2023 ET)
Compare
Today's Range
$51.31
$51.62
50-Day Range
$50.45
$57.18
52-Week Range
$36.91
$57.82
Volume
1.45 million shs
Average Volume
1.87 million shs
Market Capitalization
$129.85 billion
P/E Ratio
18.46
Dividend Yield
2.68%
Price Target
$94.50

Sanofi MarketRank™ Forecast

Analyst Rating
Hold
2.44 Rating Score
Upside/​Downside
83.5% Upside
$94.50 Price Target
Short Interest
Healthy
0.15% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.50mentions of Sanofi in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.05%
From $4.47 to $4.83 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.39 out of 5 stars

Medical Sector

142nd out of 981 stocks

Pharmaceutical Preparations Industry

58th out of 459 stocks


SNY stock logo

About Sanofi (NASDAQ:SNY) Stock

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Receive SNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter.

SNY Stock News Headlines

Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential (SNY)
These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside.
Why Your IRA Could Crash on June 16th
China will attack Taiwan as soon as June 16th, 2023. The stock market will crash at least 35% when China makes their move.
Sanofi (NASDAQ:SNY) Shares Gap Down to $52.51
Brokerages Set Sanofi (NASDAQ:SNY) PT at $93.50
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Sanofi (NASDAQ:SNY) Declares $1.38 Annual Dividend
2 Bear Market Defying Stocks to Buy in May
Sanofi (NYSE:SNY) Downgraded by StockNews.com
Peering Into Sanofi's Recent Short Interest
Sanofi (NYSE:SNY) Downgraded to Buy at StockNews.com
See More Headlines

SNY Price History

SNY Company Calendar

Last Earnings
4/27/2023
Ex-Dividend for 6/23 Dividend
5/30/2023
Today
6/06/2023
Dividend Payable
6/23/2023
Next Earnings (Estimated)
7/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SNY
Employees
91,573
Year Founded
2004

Price Target and Rating

Average Stock Price Forecast
$94.50
High Stock Price Forecast
$119.00
Low Stock Price Forecast
$60.00
Forecasted Upside/Downside
+83.5%
Consensus Rating
Hold
Rating Score (0-4)
2.44
Research Coverage
9 Analysts

Profitability

Net Income
$8.82 billion
Pretax Margin
24.33%

Debt

Sales & Book Value

Annual Sales
$45.31 billion
Cash Flow
$5.80 per share
Book Value
$31.40 per share

Miscellaneous

Outstanding Shares
2,521,930,000
Free Float
2,496,708,000
Market Cap
$129.85 billion
Optionable
Optionable
Beta
0.57

Social Links


Key Executives

  • Paul HudsonPaul Hudson
    Chief Executive Officer & Director
  • Jean-Baptiste Chasseloup de ChatillonJean-Baptiste Chasseloup de Chatillon
    Chief Financial Officer & Executive Vice President
  • Nestle Frank
    Global Head-Immunology Therapeutic Research Area
  • Dietmar P. Berger
    Chief Medical Officer & Global Head-Development
  • Natalie Bickford
    Chief People Officer & Executive Vice President













SNY Stock - Frequently Asked Questions

Should I buy or sell Sanofi stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sanofi in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SNY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNY, but not buy additional shares or sell existing shares.
View SNY analyst ratings
or view top-rated stocks.

What is Sanofi's stock price forecast for 2023?

9 brokerages have issued 12-month price objectives for Sanofi's stock. Their SNY share price forecasts range from $60.00 to $119.00. On average, they anticipate the company's stock price to reach $94.50 in the next twelve months. This suggests a possible upside of 83.5% from the stock's current price.
View analysts price targets for SNY
or view top-rated stocks among Wall Street analysts.

How have SNY shares performed in 2023?

Sanofi's stock was trading at $48.43 on January 1st, 2023. Since then, SNY stock has increased by 6.3% and is now trading at $51.49.
View the best growth stocks for 2023 here
.

When is Sanofi's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our SNY earnings forecast
.

How were Sanofi's earnings last quarter?

Sanofi (NASDAQ:SNY) released its quarterly earnings data on Thursday, April, 27th. The company reported $1.16 EPS for the quarter, beating the consensus estimate of $1.10 by $0.06. The firm earned $10.97 billion during the quarter, compared to the consensus estimate of $11.60 billion. Sanofi had a net margin of 15.41% and a trailing twelve-month return on equity of 28.45%.

How often does Sanofi pay dividends? What is the dividend yield for Sanofi?

Sanofi declared an annual dividend on Tuesday, May 30th. Shareholders of record on Wednesday, May 31st will be paid a dividend of $1.377 per share on Friday, June 23rd. This represents a yield of 2.94%. The ex-dividend date of this dividend is Tuesday, May 30th.
Read our dividend analysis for SNY
.

Is Sanofi a good dividend stock?

Sanofi (NASDAQ:SNY) pays an annual dividend of $1.38 per share and currently has a dividend yield of 2.70%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 49.46%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SNY will have a dividend payout ratio of 28.57% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SNY.

What is Paul Hudson's approval rating as Sanofi's CEO?

277 employees have rated Sanofi Chief Executive Officer Paul Hudson on Glassdoor.com. Paul Hudson has an approval rating of 94% among the company's employees. This puts Paul Hudson in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Sanofi own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanofi investors own include AbbVie (ABBV), Abbott Laboratories (ABT), Adobe (ADBE), Amgen (AMGN), Broadcom (AVGO), Boeing (BA), Alibaba Group (BABA), Bank of America (BAC) and BP (BP).

What is Sanofi's stock symbol?

Sanofi trades on the NASDAQ under the ticker symbol "SNY."

Who are Sanofi's major shareholders?

Sanofi's stock is owned by a variety of institutional and retail investors. Top institutional investors include Dodge & Cox (3.27%), FMR LLC (0.92%), Boston Partners (0.71%), Fisher Asset Management LLC (0.53%), Bank of America Corp DE (0.42%) and BlackRock Inc. (0.40%).
View institutional ownership trends
.

How do I buy shares of Sanofi?

Shares of SNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sanofi's stock price today?

One share of SNY stock can currently be purchased for approximately $51.49.

How much money does Sanofi make?

Sanofi (NASDAQ:SNY) has a market capitalization of $129.85 billion and generates $45.31 billion in revenue each year. The company earns $8.82 billion in net income (profit) each year or $2.79 on an earnings per share basis.

How many employees does Sanofi have?

The company employs 91,573 workers across the globe.

Does Sanofi have any subsidiaries?
The following companies are subsidiares of Sanofi: A. Nattermann & Cie. GmbH, AO Sanofi Russia, Ablynx, Ablynx N.V., Allston Landing Limited Partnership, Aventis Inc., Aventis Pharma (Manufacturing) Pte. Ltd, Aventis Pharma Limited, Aventis Pharma S.A., Aventis S.A., Aventisub LLC, Bioverativ, Bioverativ Inc., Bioverativ Therapeutics Inc., Bioverativ U.S.LLC, Carraig Insurance DAC, Chattem Inc., Chinoin Private Co. Ltd, Francopia, Genfar S.A., Genzyme Corporation, Genzyme Europe B.V., Genzyme Flanders BVBA, Genzyme Global Sarl, Genzyme Ireland Limited, Genzyme Limited, Genzyme Polyclonals SAS, Genzyme Therapeutic Products Limited Partnership, Genzyme Therapeutics Limited, Genzyme de Argentina S.A., Hoechst GmbH, Kiadis Pharma, Limited Liability Company Sanofi-Aventis Ukraine, PT Aventis Pharma, Principia BioPharma, SSP Co. Ltd, Sanofi (Beijing) Pharmaceuticals Co.Ltd, Sanofi (China) Investment Co. Ltd, Sanofi (Hangzhou) Pharmaceuticals Co. Ltd, Sanofi A/S, Sanofi AB, Sanofi Arabia Trading Company Limited, Sanofi Aventis NA Holding Inc., Sanofi Belgium, Sanofi Biotechnology, Sanofi Chimie, Sanofi Egypt, Sanofi Finance Ireland limited, Sanofi Foreign Participations B.V., Sanofi Healthcare India Private Limited, Sanofi Ilac Sanayi ve Ticaret A.S., Sanofi India Limited, Sanofi K.K., Sanofi Mature IP, Sanofi Medley Farmaceutica Ltda, Sanofi Nichi-Iko K.K., Sanofi Oy, Sanofi Pasteur, Sanofi Pasteur Asi Ticaret A.S., Sanofi Pasteur Biologies Co. Ltd, Sanofi Pasteur Europe, Sanofi Pasteur Inc., Sanofi Pasteur India Private Ltd, Sanofi Pasteur Limited, Sanofi Pasteur Ltd, Sanofi Pasteur NVL, Sanofi Pasteur S.A. de C.V., Sanofi Produtos Farmaceuticos Lda, Sanofi Romania SRL, Sanofi S.p.A., Sanofi Saglik Urunleri Limited Sirketi, Sanofi Taiwan Co. Ltd, Sanofi US Corporation, Sanofi US Services Inc., Sanofi Vaccine Technologies, Sanofi Winthrop Industrie, Sanofi-Aventis (Malaysia) SDN. BHD., Sanofi-Aventis (Suisse) SA, Sanofi-Aventis (Thailand) Ltd, Sanofi-Aventis A.E.B.E., Sanofi-Aventis Algérie, Sanofi-Aventis Argentina S.A., Sanofi-Aventis Australia Pty Ltd, Sanofi-Aventis Canada Inc., Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis France, Sanofi-Aventis GmbH, Sanofi-Aventis Groupe, Sanofi-Aventis Gulf FZE, Sanofi-Aventis Healthcare Pty Ltd, Sanofi-Aventis Hong-Kong Limited, Sanofi-Aventis Ireland Ltd, Sanofi-Aventis Israël Ltd, Sanofi-Aventis Korea Co. Ltd, Sanofi-Aventis Liban s.a.l., Sanofi-Aventis Maroc, Sanofi-Aventis Netherlands B.V., Sanofi-Aventis Norge AS, Sanofi-Aventis Pakistan Limited, Sanofi-Aventis Participations, Sanofi-Aventis Philippines Inc., Sanofi-Aventis Private Co Ltd, Sanofi-Aventis Recherche & Développement, Sanofi-Aventis S.A., Sanofi-Aventis Singapore Pte. Ltd, Sanofi-Aventis South Africa (Pty) Ltd, Sanofi-Aventis Sp. z.o.o., Sanofi-Aventis U.S. LLC, Sanofi-Aventis UK Holdings Limited, Sanofi-Aventis Winthrop S.A. de C.V., Sanofi-Aventis de Colombia S.A., Sanofi-Aventis de Mexico S.A. de C.V., Sanofi-Aventis de Panama S.A., Sanofi-Aventis de Venezuela S.A., Sanofi-Aventis del Ecuador S.A., Sanofi-Aventis del Peru S.A., Sanofi-Aventis s.r.o., Sanofi-Synthelabo (India) Private Ltd, Sanofi-aventis Vietnam Company Limited, Shenzhen Sanofi pasteur Biological Products Co Ltd, Synthorx, VaxServe Inc., sanofi-aventis Puerto Rico Inc, and sanofi-aventis Slovakia s.r.o..
Read More
How can I contact Sanofi?

Sanofi's mailing address is 54 RUE LA BOETIE, PARIS I0, 75008. The official website for the company is www.sanofi.com. The company can be reached via phone at (315) 377-4000, via email at ir@sanofi.com, or via fax at 33-1-53-77-43-03.

This page (NASDAQ:SNY) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -